Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone for prevention and treatment of chemotherapy‑associated constipation in solid tumors
ChiCTR2600127325Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cobiprostone in constipation (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Incidence of constipation during chemotherapy. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
cobiprostone
03
Conditions
constipation
Beyond the preview
Go deeper on ChiCTR2600127325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127325.